Daniel Bazarko - 14 Jul 2021 Form 4 Insider Report for ALEXION PHARMACEUTICALS, INC.

Role
SVP, Controller, CAO
Signature
/s/ Douglas Barry, Attorney-in-Fact for Daniel Bazarko
Issuer symbol
N/A
Transactions as of
14 Jul 2021
Net transactions value
$0
Form type
4
Filing time
16 Jul 2021, 16:49:36 UTC
Next filing
23 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALXN Common Stock, par value $.0001 per share Award $0 +11,060 +29% $0.000000 49,559 14 Jul 2021 Direct F1
transaction ALXN Common Stock, par value $.0001 per share Award $0 +10,648 +21% $0.000000 60,207 14 Jul 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2019 under the 2017 Stock Incentive Plan.
F2 On July 14, 2021 the Leadership and Compensation Committee certified that certain performance metrics under previously granted performance stock units were satisfied. These performance stock units were previously granted in February 2020 under the 2017 Stock Incentive Plan.